换一批Pharmacokinetics of 5-fluorouracil in patients heterozygous for the IVS14+1G > A mutation in the dihydropyrimidine dehydrogenase gene.
第一作者：
A B P,van Kuilenburg
第一单位：
Academic Medical Center, Emma Children's Hospital and Department of Clinical Chemistry, University of Amsterdam, Amsterdam, The Netherlands. a.b.vankuilenburg@amc.uva.nl
作者：
医学主题词
抗肿瘤药(Antineoplastic Agents);曲线下面积(Area Under Curve);二氢嘧啶脱氢酶缺乏(Dihydropyrimidine Dehydrogenase Deficiency);二氢尿嘧啶脱氢酶(NADP)(Dihydrouracil Dehydrogenase (NADP));氟尿嘧啶(Fluorouracil);杂合子(Heterozygote);人类(Humans);代谢清除率(Metabolic Clearance Rate);突变(Mutation);肿瘤(Neoplasms)
DOI
10.1080/15257770802145009
PMID
18600527
发布时间
2013-11-21
- 浏览32
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
